Skip to content
    MDGL stock page

    MADRIGAL PHARMACEUTICALS, INC.

    MDGL · earnings call history

    2 calls analysed
    1. Jun 2026Q2 FY26Jul 30, 2026

      Madrigal Pharmaceuticals Q2 FY26 — Rezdiffra Exceeds Expectations with Strong Patient Adds and Robust Sales Growth

      Read the brief
    2. Mar 2026Q1 FY26May 06, 2026

      Madrigal Pharmaceuticals Q1 FY26 — Rezdiffra Blockbuster Status & Pipeline Expansion

      Read the brief

    Browse all US companies on the earnings-call register.